By Elric Langton | 15 October 2021
Poolbeg Pharma (AIM: POLB), a clinical-stage infectious disease pharmaceutical company with a capital-light clinical model, updates new patent filings for its PredictViral™ platform that estimates disease severity and contagiousness in people who are recently infected with a respiratory virus.
Expanding on existing Predi…